Modulating the L-arginine-nitric oxide pathway in septic shock: choosing the proper point of attack.
Fink
M P
MP
D000818:Animals; D001120:Arginine / Q000378:metabolism*; D004791:Enzyme Inhibitors / Q000494:pharmacology; D006162:Guanylate Cyclase / Q000378:metabolism; D006801:Humans; D051379:Mice; D009569:Nitric Oxide / Q000378:metabolism*; D019001:Nitric Oxide Synthase / Q000378:metabolism*; D010069:Oxadiazoles / Q000494:pharmacology; D051381:Rats; D012772:Shock, Septic / Q000201:enzymology / Q000503:physiopathology*
D004791:Enzyme Inhibitors; D010069:Oxadiazoles; D009569:Nitric Oxide; D001120:Arginine; D019001:Nitric Oxide Synthase; D006162:Guanylate Cyclase